Rapid Micro Biosystems Inc. (RPID): Forecast Levels Chart

The Rapid Micro Biosystems (RPID) price chart demonstrates business resilience backed by stable revenue from service maintenance and the sale of consumables. The current indicator is 5.97. Rapid Micro Biosystems is implementing cleanliness control automation in collaboration with pharmaceutical industry leaders. However, prolonged deal cycles, dependence on client capital expenditures, and the potential emergence of alternative diagnostic technologies are weighing on margins.

Rapid Micro (RPID): Analyst Consensus Forecast from 07/04/2022 to 11/11/2026

Analytical breakdowns for Rapid Micro Biosystems (RPID)

- share price and consensus valuation forecast:

Price Performance Chart rapidmicrobio.com|RPID - Price Target Chart

- stock exchange capitalization data:

Market Valuation Rapid Micro|RPID - Enterprise Value

- balance sheet net asset value indicators:

Net Assets per Share Rapid Micro Biosystems|RPID - Book Capitalization|Capitalization to Book Value Ratio rapidmicrobio.com|RPID - Company Total Assets

- debt obligations and liquidity statistics:

- net income and valuation ratios data:

RPID - Company Net Income|Expected Net Profit Rapid Micro Biosystems|RPID - Price to Earnings Ratio|Market Cap to Projected Earnings rapidmicrobio.com|RPID - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Rapid Micro|RPID - Operating profit EBITDA|Net earnings per share for the last four quarters Rapid Micro Biosystems|RPID - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months rapidmicrobio.com|RPID - Net earnings per share growth this year|Expected earnings per share trend next year Rapid Micro Biosystems

General company analysis:RPID Rapid Micro Biosystems Inc.

Manufactured products of Rapid Micro Biosystems Inc.

This indicator represents the weighted average of target prices from industry experts, allowing investors to filter out volatile market noise and determine the asset's fair value. By analyzing the aggregate market consensus target, one can assess the potential of Rapid Micro Biosystems (RPID), whose capitalization depends directly on the efficiency of microbial control automation within strategic partnerships with pharmaceutical behemoths.

Competing companies